Status:
COMPLETED
Transfoveal Micropulse Laser for Center Involving Diabetic Macular Edema
Lead Sponsor:
Cairo University
Conditions:
Diabetic Retinopathy
Macula Edema
Eligibility:
All Genders
20-80 years
Phase:
PHASE4
Brief Summary
Anti-vascular endothelial growth factor (VEGF) therapy is currently the mainstay of treatment for diabetic macular edema (DME). One of the main obstacles of anti-VEGF therapy is the need of repeated i...
Detailed Description
This was a prospective randomized comparative study that included 30 eyes of 15 patients with bilateral DME. The patients were recruited from the Retina Clinic at Kasr Al Ainy Hospital, Cairo Universi...
Eligibility Criteria
Inclusion
- bilateral diabetic macular edema
- center involving confirmed by Optical coherence tomogram (OCT)
Exclusion
- any non-diabetic macular edema
- significant media opacities
- previous laser treatment, any intraocular surgery within the past 6 months
- previous intravitreal injections of any drug within the past 6 months
Key Trial Info
Start Date :
January 22 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 25 2018
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04359771
Start Date
January 22 2018
End Date
September 25 2018
Last Update
June 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Cairo University
Cairo, Egypt, 11562